David Healthcare (300314.SZ) released its 2023 annual report. The company's revenue was 618 million yuan...
According to the Zhitong Finance App, David Healthcare (300314.SZ) released its 2023 annual report. The company's revenue was 618 million yuan, an increase of 22.18% over the previous year. Net profit attributable to shareholders of listed companies was 148 million yuan, an increase of 51.62% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was $129 million, an increase of 61.78% over the previous year. Basic earnings per share were $0.51.
During the reporting period, the company's pediatric obstetrics care equipment business achieved operating income of 358 million yuan, accounting for 59.05% of the main business revenue, an increase of 20.17% over the same period of the previous year; the minimally invasive surgical instruments business achieved revenue of 245 million yuan, accounting for 40.37% of the main business revenue, an increase of 24.48% over the same period last year.
In addition, it is proposed to distribute a cash dividend of 1.80 yuan (tax included) for every 10 shares to all shareholders.